WPRIM Management System> DCMS> Journal of Lipid and Atherosclerosis> 2018> 7> 1

Volume: 7 Issue: 1

1. How to Interpret Recent CV Outcome Trials and Future: PCSK9 Inhibitors. Page:1—11
2. What Do We Get from Recent Statin and CETP Inhibitors Trials?. Page:12—20
3. Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitor and Its Possible Cardioprotective Mechanism. Page:21—31
4. Cardiovascular Outcome Trials of Incretin Therapy (Dipeptidyl Peptidase-4 Inhibitors/Glucagon-Like Peptide-1 Receptor Agonist). Page:32—41
5. Relationship between Circulating FGF21 Concentrations and the Severity of Coronary Artery Damage in Subjects with Cardiovascular Disease. Page:42—49
6. Early Valuable Risk Stratification with Hemoglobin Level and Neutrophil to Lymphocyte Ratio in Patients with Non-ST-Elevation Myocardial Infarction Having an Early Invasive Strategy. Page:50—61
7. Contrast-free (Zero-contrast) TAVR for Severe Aortic Stenosis in Patient with Chronic Kidney Disease. Page:62—67
8. Successful Treatment of Coronary Spasm with Atherosclerosis Rapidly Progressing to Acute Myocardial Infarction in a Young Woman. Page:68—75

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.